For years, the functional service provider (FSP) model has given sponsors a practical way to extend internal teams and access ...
Maternity care is one of the most fundamental components of any healthcare system. It shapes not only the health of mothers ...
AbbVie has received European Commission approval for Rinvoq to treat active polyarticular juvenile idiopathic arthritis in ...
Wherever two or more MedTech start-up founders gather, the conversation follows the same depressingly familiar pattern. In the breakout areas and coffee bars of conferences and symposia around the ...
Merck has announced that NICE has issued final draft guidance recommending Ogsiveo for adults in England with progressing desmoid tumours who require systemic treatment. Eligible patients will gain ...
It is a testament to investor success that over 100 exhibitors at CPHI 2026 have some form of PE ownership across the entire ...
Lexeo Therapeutics has signed an agreement to acquire Mantle Therapeutics and launched several new collaborations aimed at ...
AC Immune has reported positive week-100 results from part 1 of its phase 2 VacSyn trial evaluating ACI-7104 in early-stage ...
Grünenthal has entered a new partnership with DKSH to expand access to four established pain medicines across Asia-Pacific.
Johnson & Johnson has reported new long-term data showing that half of patients in early line relapsed or refractory multiple myeloma remained alive and progression-free for at least five years after ...
Ethiopia, Norway and the UK have pledged US$240 million to support CEPI’s five‑year plan to strengthen global readiness for epidemic and pandemic threats. Ethiopia will contin ...
Sanofi and Cheplapharm have announced plans to establish a new strategic partnership that will see Cheplapharm take over 20 mature medicines and three manufacturing sites worldwide. The agreement will ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results